Skip to content
AnalystLens
Back to ONCBalance Sheet

BeOne Medicines Ltd. Long-Term Debt 2015-2026 | ONC

Annual FY2015–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$961.9M

+477.8%YoY vs FY2024Source: 10-KFY2025

From $6.2M in FY2015 to $961.9M in FY2025: 155.4× in 10 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$963M+501.0%Not reportedNot reportedNot reported
FY25$160M−19.5%$146M−21.1%Not reported$962M+477.8%
FY24$199M−3.5%$185M−10.7%$188M−7.4%$166M−15.8%
FY23$206M+2.3%$207M+12.0%$202M−2.7%$198M−5.5%
FY22$202M+4.4%$185M−5.0%$208M+3.6%$209M+3.5%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+39.3%

FY2020
$183.6M
FY2025
$961.9M

5 years selected · on the chart

01—History

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  11. $961.9M
YoY changeLargest recent move+120.4%in FY20Latest +477.8%

3 older moves run past ±150% (largest +477.8%); point at, tap or drag across the bars to read one.

02—Ledger

Long-Term Debt, period by period

PeriodValueChangeSource
FY2025$961.9M+477.8%10-K
FY2024$166.5M−15.8%10-K
FY2023$197.6M−5.5%10-K
FY2022$209.1M+3.5%10-K
FY2021$202.1M+10.1%10-K
FY2020$183.6M+120.4%10-K
FY2019$83.3M+104.3%10-K
FY2018$40.8M+342.3%10-K
FY2017$9.2M−46.6%10-K
FY2016$17.3M+179.3%10-K
FY2015$6.2M—10-K

03—Questions

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is BeOne Medicines Ltd.'s current long-term debt?

BeOne Medicines Ltd. (ONC) annual long-term debt for 2025 was $961.9M, a 477.78% increase from 2024. BeOne Medicines Ltd. long-term debt for the quarter ending March 31, 2026 was $962.5M.

What was BeOne Medicines Ltd.'s long-term debt in 2024?

BeOne Medicines Ltd. annual long-term debt for 2024 was $166.5M, a 15.75% decline from 2023.

What was BeOne Medicines Ltd.'s long-term debt in 2023?

BeOne Medicines Ltd. annual long-term debt for 2023 was $197.6M, a 5.51% decline from 2022.

What is BeOne Medicines Ltd.'s 5-year long-term debt CAGR?

BeOne Medicines Ltd. long-term debt grew at a compound annual growth rate (CAGR) of 39.26% from FY2020 to FY2025, going from $183.6M to $961.9M over 5 years.

Company
BeOne Medicines Ltd.
Ticker
ONC
Sector
Healthcare
Industry
Pharmaceutical Preparations
View company profile →